• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

热休克蛋白 90 共伴侣蛋白,亲环素 40,促进间变性大细胞淋巴瘤 ALK 阳性细胞的存活,其表达受 NPM-ALK 癌蛋白的调控。

The heat shock protein-90 co-chaperone, Cyclophilin 40, promotes ALK-positive, anaplastic large cell lymphoma viability and its expression is regulated by the NPM-ALK oncoprotein.

机构信息

Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Canada.

出版信息

BMC Cancer. 2012 Jun 8;12:229. doi: 10.1186/1471-2407-12-229.

DOI:10.1186/1471-2407-12-229
PMID:22681779
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3407532/
Abstract

BACKGROUND

Anaplastic lymphoma kinase-positive, anaplastic large cell lymphoma (ALK+ ALCL) is a T cell lymphoma defined by the presence of chromosomal translocations involving the ALK tyrosine kinase gene. These translocations generate fusion proteins (e.g. NPM-ALK) with constitutive tyrosine kinase activity, which activate numerous signalling pathways important for ALK+ ALCL pathogenesis. The molecular chaperone heat shock protein-90 (Hsp90) plays a critical role in allowing NPM-ALK and other signalling proteins to function in this lymphoma. Co-chaperone proteins are important for helping Hsp90 fold proteins and for directing Hsp90 to specific clients; however the importance of co-chaperone proteins in ALK+ ALCL has not been investigated. Our preliminary findings suggested that expression of the immunophilin co-chaperone, Cyclophilin 40 (Cyp40), is up-regulated in ALK+ ALCL by JunB, a transcription factor activated by NPM-ALK signalling. In this study we examined the regulation of the immunophilin family of co-chaperones by NPM-ALK and JunB, and investigated whether the immunophilin co-chaperones promote the viability of ALK+ ALCL cell lines.

METHODS

NPM-ALK and JunB were knocked-down in ALK+ ALCL cell lines with siRNA, and the effect on the expression of the three immunophilin co-chaperones: Cyp40, FK506-binding protein (FKBP) 51, and FKBP52 examined. Furthermore, the effect of knock-down of the immunophilin co-chaperones, either individually or in combination, on the viability of ALK+ ALCL cell lines and NPM-ALK levels and activity was also examined.

RESULTS

We found that NPM-ALK promoted the transcription of Cyp40 and FKBP52, but only Cyp40 transcription was promoted by JunB. We also observed reduced viability of ALK+ ALCL cell lines treated with Cyp40 siRNA, but not with siRNAs directed against FKBP52 or FKBP51. Finally, we demonstrate that the decrease in the viability of ALK+ ALCL cell lines treated with Cyp40 siRNA does not appear to be due to a decrease in NPM-ALK levels or the ability of this oncoprotein to signal.

CONCLUSIONS

This is the first study demonstrating that the expression of immunophilin family co-chaperones is promoted by an oncogenic tyrosine kinase. Moreover, this is the first report establishing an important role for Cyp40 in lymphoma.

摘要

背景

间变性淋巴瘤激酶阳性间变大细胞淋巴瘤(ALK+ ALCL)是一种 T 细胞淋巴瘤,其特征是存在涉及 ALK 酪氨酸激酶基因的染色体易位。这些易位产生具有组成型酪氨酸激酶活性的融合蛋白(例如 NPM-ALK),其激活对于 ALK+ ALCL 发病机制很重要的许多信号通路。分子伴侣热休克蛋白-90(Hsp90)在允许 NPM-ALK 和其他信号蛋白在这种淋巴瘤中发挥作用方面起着至关重要的作用。伴侣蛋白对于帮助 Hsp90 折叠蛋白质和指导 Hsp90 到特定客户非常重要;然而,伴侣蛋白在 ALK+ ALCL 中的重要性尚未得到研究。我们的初步研究结果表明,免疫亲和素伴侣蛋白环孢素 40(Cyp40)的表达通过 NPM-ALK 信号传导激活的转录因子 JunB 在 ALK+ ALCL 中上调。在这项研究中,我们研究了 NPM-ALK 和 JunB 对免疫亲和素家族伴侣蛋白的调节作用,并研究了免疫亲和素伴侣蛋白是否促进 ALK+ ALCL 细胞系的存活。

方法

用 siRNA 敲低 ALK+ ALCL 细胞系中的 NPM-ALK 和 JunB,并研究对三种免疫亲和素伴侣蛋白的表达的影响:Cyp40、FK506 结合蛋白(FKBP)51 和 FKBP52。此外,还研究了单独或组合敲低免疫亲和素伴侣蛋白对 ALK+ ALCL 细胞系的活力以及 NPM-ALK 水平和活性的影响。

结果

我们发现 NPM-ALK 促进 Cyp40 和 FKBP52 的转录,但只有 JunB 促进 Cyp40 的转录。我们还观察到用 Cyp40 siRNA 处理的 ALK+ ALCL 细胞系活力降低,但用针对 FKBP52 或 FKBP51 的 siRNA 处理则没有。最后,我们证明用 Cyp40 siRNA 处理的 ALK+ ALCL 细胞系活力降低似乎不是由于 NPM-ALK 水平降低或这种致癌蛋白信号转导能力降低所致。

结论

这是第一项证明免疫亲和素家族伴侣蛋白的表达受致癌酪氨酸激酶促进的研究。此外,这是第一项证明 Cyp40 在淋巴瘤中具有重要作用的报告。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51ff/3407532/2160296ed906/1471-2407-12-229-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51ff/3407532/9c09cbb45959/1471-2407-12-229-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51ff/3407532/edc5d0cdba03/1471-2407-12-229-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51ff/3407532/847f1568e1c4/1471-2407-12-229-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51ff/3407532/b69ab44fe0df/1471-2407-12-229-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51ff/3407532/004bed79da4a/1471-2407-12-229-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51ff/3407532/f8e6e863c3d9/1471-2407-12-229-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51ff/3407532/2160296ed906/1471-2407-12-229-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51ff/3407532/9c09cbb45959/1471-2407-12-229-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51ff/3407532/edc5d0cdba03/1471-2407-12-229-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51ff/3407532/847f1568e1c4/1471-2407-12-229-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51ff/3407532/b69ab44fe0df/1471-2407-12-229-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51ff/3407532/004bed79da4a/1471-2407-12-229-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51ff/3407532/f8e6e863c3d9/1471-2407-12-229-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51ff/3407532/2160296ed906/1471-2407-12-229-7.jpg

相似文献

1
The heat shock protein-90 co-chaperone, Cyclophilin 40, promotes ALK-positive, anaplastic large cell lymphoma viability and its expression is regulated by the NPM-ALK oncoprotein.热休克蛋白 90 共伴侣蛋白,亲环素 40,促进间变性大细胞淋巴瘤 ALK 阳性细胞的存活,其表达受 NPM-ALK 癌蛋白的调控。
BMC Cancer. 2012 Jun 8;12:229. doi: 10.1186/1471-2407-12-229.
2
NPM-ALK and the JunB transcription factor regulate the expression of cytotoxic molecules in ALK-positive, anaplastic large cell lymphoma.NPM-ALK和JunB转录因子调节ALK阳性间变性大细胞淋巴瘤中细胞毒性分子的表达。
Int J Clin Exp Pathol. 2011 Jan 30;4(2):124-33.
3
The oncoprotein NPM-ALK of anaplastic large-cell lymphoma induces JUNB transcription via ERK1/2 and JunB translation via mTOR signaling.间变性大细胞淋巴瘤的癌蛋白NPM-ALK通过ERK1/2诱导JUNB转录,并通过mTOR信号传导诱导JunB翻译。
Blood. 2007 Nov 1;110(9):3374-83. doi: 10.1182/blood-2007-02-071258. Epub 2007 Aug 9.
4
Prognostic significance and therapeutic potential of the activation of anaplastic lymphoma kinase/protein kinase B/mammalian target of rapamycin signaling pathway in anaplastic large cell lymphoma.间变性大细胞淋巴瘤中间变性淋巴瘤激酶/蛋白激酶B/雷帕霉素哺乳动物靶标信号通路激活的预后意义及治疗潜力
BMC Cancer. 2013 Oct 10;13:471. doi: 10.1186/1471-2407-13-471.
5
Nucleophosmin-anaplastic lymphoma kinase: the ultimate oncogene and therapeutic target.核仁磷酸蛋白-间变性淋巴瘤激酶:终极致癌基因和治疗靶点。
Blood. 2017 Feb 16;129(7):823-831. doi: 10.1182/blood-2016-05-717793. Epub 2016 Nov 22.
6
Silibinin suppresses NPM-ALK, potently induces apoptosis and enhances chemosensitivity in ALK-positive anaplastic large cell lymphoma.水飞蓟宾可抑制核仁磷酸蛋白-间变性淋巴瘤激酶(NPM-ALK),有效诱导细胞凋亡,并增强ALK阳性间变性大细胞淋巴瘤的化疗敏感性。
Leuk Lymphoma. 2016 May;57(5):1154-62. doi: 10.3109/10428194.2015.1068306. Epub 2015 Jul 1.
7
Nucleophosmin-anaplastic lymphoma kinase (NPM-ALK), a novel Hsp90-client tyrosine kinase: down-regulation of NPM-ALK expression and tyrosine phosphorylation in ALK(+) CD30(+) lymphoma cells by the Hsp90 antagonist 17-allylamino,17-demethoxygeldanamycin.核磷蛋白-间变性淋巴瘤激酶(NPM-ALK),一种新型的热休克蛋白90(Hsp90)底物酪氨酸激酶:热休克蛋白90拮抗剂17-烯丙基氨基-17-去甲氧基格尔德霉素对ALK(+) CD30(+)淋巴瘤细胞中NPM-ALK表达及酪氨酸磷酸化的下调作用
Cancer Res. 2002 Mar 1;62(5):1559-66.
8
STAT1 is phosphorylated and downregulated by the oncogenic tyrosine kinase NPM-ALK in ALK-positive anaplastic large-cell lymphoma.STAT1 被致癌酪氨酸激酶 NPM-ALK 在 ALK 阳性间变大细胞淋巴瘤中磷酸化和下调。
Blood. 2015 Jul 16;126(3):336-45. doi: 10.1182/blood-2014-10-603738. Epub 2015 Apr 28.
9
The HSP90 inhibitor 17-AAG synergizes with doxorubicin and U0126 in anaplastic large cell lymphoma irrespective of ALK expression.热休克蛋白90(HSP90)抑制剂17-AAG与阿霉素和U0126在间变性大细胞淋巴瘤中具有协同作用,与间变性淋巴瘤激酶(ALK)表达无关。
Exp Hematol. 2006 Dec;34(12):1670-9. doi: 10.1016/j.exphem.2006.07.002.
10
The expression of CD30 in anaplastic large cell lymphoma is regulated by nucleophosmin-anaplastic lymphoma kinase-mediated JunB level in a cell type-specific manner.间变性大细胞淋巴瘤中CD30的表达由核磷蛋白-间变性淋巴瘤激酶以细胞类型特异性方式介导的JunB水平调控。
Cancer Res. 2006 Sep 15;66(18):9002-8. doi: 10.1158/0008-5472.CAN-05-4101.

引用本文的文献

1
Proline Isomerization: From the Chemistry and Biology to Therapeutic Opportunities.脯氨酸异构化:从化学与生物学至治疗机遇
Biology (Basel). 2023 Jul 14;12(7):1008. doi: 10.3390/biology12071008.
2
Broad-spectrum antitumor properties of Withaferin A: a proteomic perspective.Withaferin A的广谱抗肿瘤特性:蛋白质组学视角
RSC Med Chem. 2019 Dec 16;11(1):30-50. doi: 10.1039/c9md00296k. eCollection 2020 Jan 1.
3
AP-1 family transcription factors: a diverse family of proteins that regulate varied cellular activities in classical hodgkin lymphoma and ALK+ ALCL.

本文引用的文献

1
Favorable response to crizotinib in three patients with echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase fusion-type oncogene-positive non-small cell lung cancer.三例棘皮动物微管相关蛋白样 4-间变性淋巴瘤激酶融合型癌基因阳性非小细胞肺癌患者对克唑替尼的良好反应。
Cancer Sci. 2011 Aug;102(8):1602-4. doi: 10.1111/j.1349-7006.2011.01970.x.
2
ALK fusion gene positive lung cancer and 3 cases treated with an inhibitor for ALK kinase activity.ALK 融合基因阳性肺癌及 3 例 ALK 激酶活性抑制剂治疗病例。
Lung Cancer. 2012 Jan;75(1):66-72. doi: 10.1016/j.lungcan.2011.05.027. Epub 2011 Jul 14.
3
Therapeutic strategies to overcome crizotinib resistance in non-small cell lung cancers harboring the fusion oncogene EML4-ALK.
AP-1家族转录因子:一类多样化的蛋白质家族,可调节经典型霍奇金淋巴瘤和ALK阳性间变性大细胞淋巴瘤中的多种细胞活动。
Exp Hematol Oncol. 2021 Jan 7;10(1):4. doi: 10.1186/s40164-020-00197-9.
4
Biological Actions of the Hsp90-binding Immunophilins FKBP51 and FKBP52.热休克蛋白 90 结合免疫亲和素 FKBP51 和 FKBP52 的生物学作用。
Biomolecules. 2019 Feb 1;9(2):52. doi: 10.3390/biom9020052.
5
Molecular dynamics simulations of site point mutations in the TPR domain of cyclophilin 40 identify conformational states with distinct dynamic and enzymatic properties.分子动力学模拟环孢素 40 的 TPR 结构域中的位点突变,确定了具有不同动态和酶学特性的构象状态。
J Chem Phys. 2018 Apr 14;148(14):145101. doi: 10.1063/1.5019457.
6
Expression patterns of the activator protein-1 (AP-1) family members in lymphoid neoplasms.淋巴肿瘤中激活蛋白-1(AP-1)家族成员的表达模式。
Clin Exp Med. 2017 Aug;17(3):291-304. doi: 10.1007/s10238-016-0436-z. Epub 2016 Sep 6.
7
Steroid Receptor-Associated Immunophilins: A Gateway to Steroid Signalling.类固醇受体相关亲免素:通往类固醇信号传导的门户
Clin Biochem Rev. 2015 May;36(2):31-52.
8
Cleavage of the JunB transcription factor by caspases generates a carboxyl-terminal fragment that inhibits activator protein-1 transcriptional activity.半胱天冬酶切割 JunB 转录因子生成羧基末端片段,抑制激活蛋白-1 的转录活性。
J Biol Chem. 2013 Jul 26;288(30):21482-95. doi: 10.1074/jbc.M113.485672. Epub 2013 Jun 9.
9
The pathobiology of the oncogenic tyrosine kinase NPM-ALK: a brief update.致癌酪氨酸激酶 NPM-ALK 的病理生物学:简要更新。
Ther Adv Hematol. 2013 Apr;4(2):119-31. doi: 10.1177/2040620712471553.
克服携带融合癌基因 EML4-ALK 的非小细胞肺癌对克唑替尼耐药的治疗策略。
Proc Natl Acad Sci U S A. 2011 May 3;108(18):7535-40. doi: 10.1073/pnas.1019559108. Epub 2011 Apr 18.
4
Crizotinib in anaplastic large-cell lymphoma.克唑替尼治疗间变性大细胞淋巴瘤
N Engl J Med. 2011 Feb 24;364(8):775-6. doi: 10.1056/NEJMc1013224.
5
NPM-ALK and the JunB transcription factor regulate the expression of cytotoxic molecules in ALK-positive, anaplastic large cell lymphoma.NPM-ALK和JunB转录因子调节ALK阳性间变性大细胞淋巴瘤中细胞毒性分子的表达。
Int J Clin Exp Pathol. 2011 Jan 30;4(2):124-33.
6
The Hsp90 inhibitor IPI-504 rapidly lowers EML4-ALK levels and induces tumor regression in ALK-driven NSCLC models.Hsp90 抑制剂 IPI-504 可迅速降低 EML4-ALK 水平,并在 ALK 驱动的 NSCLC 模型中诱导肿瘤消退。
Oncogene. 2011 Jun 2;30(22):2581-6. doi: 10.1038/onc.2010.625. Epub 2011 Jan 24.
7
Anaplastic large cell lymphoma: twenty-five years of discovery.间变大细胞淋巴瘤:二十五年的探索历程。
Arch Pathol Lab Med. 2011 Jan;135(1):19-43. doi: 10.5858/2010-0507-RAR.1.
8
Identification of cyclophilin-40-interacting proteins reveals potential cellular function of cyclophilin-40.鉴定亲环素 40 相互作用蛋白揭示亲环素 40 的潜在细胞功能。
Anal Biochem. 2011 Mar 15;410(2):257-65. doi: 10.1016/j.ab.2010.12.007. Epub 2010 Dec 10.
9
The role of FKBP5 in cancer aetiology and chemoresistance.FKBP5 在癌症病因学和化疗耐药中的作用。
Br J Cancer. 2011 Jan 4;104(1):19-23. doi: 10.1038/sj.bjc.6606014. Epub 2010 Nov 30.
10
The neuroblastoma-associated F1174L ALK mutation causes resistance to an ALK kinase inhibitor in ALK-translocated cancers.神经母细胞瘤相关的 F1174L ALK 突变导致 ALK 易位癌症对 ALK 激酶抑制剂产生耐药性。
Cancer Res. 2010 Dec 15;70(24):10038-43. doi: 10.1158/0008-5472.CAN-10-2956. Epub 2010 Oct 28.